id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-002240-38aabxh1	Prina, Elena	New aspects in the management of pneumonia	2016-10-01		.txt	text/plain	4832	216	35	The administration of intravenous immunoglobulins seems to reinforce the immune response to the infection in particular in patients with inadequate levels of antibodies and when an enriched IgM preparation has been used; however, more studies are needed to determinate their impact on outcome and to define the population that will receive more benefit. Despite the use of early and appropriate antibiotic treatment, mortality related to community-acquired pneumonia (CAP) is still high [1] , especially in patients with severe disease. In contrast, another meta-analysis [25] demonstrated a reduction in all causes of mortality in patients receiving corticosteroids (12 trials, 1974 In conclusion, all these studies confirm that the use of corticosteroids in CAP is associated with the following benefits: reduced length of hospital stay, reduced time to clinical stability, and prevention of ARDS. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial	./cache/cord-002240-38aabxh1.txt	./txt/cord-002240-38aabxh1.txt